EUVIMEDEUVIMED entdecken
Übersichtsarbeit

D-Dimer as Biomarker for Prognosis of Coronary Artery Disease and Heart Failure: Reappraisal of Its Central Role

Kainuo Wu, Jonathan Van Name, Lei Xi

Cardiology · 08.05.2025 · 151 (2) · 181-191

DOI: 10.1159/000546154 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiology, online erschienen am 08.05.2025. Verfasst von Kainuo Wu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Virginia Tech Carilion School of Medicine, Roanoke, Virginia, USA, kwu@carilionclinic.org. Hauptthemen laut MEDLINE: Fibrin Fibrinogen Degradation Products, Heart Failure, Coronary Artery Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: D-dimer is a fibrinogen degradation product formed by the breakdown of cross-linked fibrin in a series of enzyme-mediated steps. Since the D-dimer assay allows for detection of thrombin production and endogenous fibrinolysis, it has been increasingly used in clinics as a screening test to exclude venous thromboembolism and disseminated intravascular coagulation. Additionally, D-dimer has been evaluated for determining the initiation of anticoagulation therapy in patients with selected cardiovascular disease. Summary: This narrative review has evaluated the updated evidence from several recent clinical studies/trials and provides a reappraisal of the utility of D-dimer assay for disease prognosis and clinical management decisions in patients with stable coronary artery disease, acute coronary syndrome, and heart failure. We further discussed several confounding factors that may affect circulating levels of D-dimer, including those observed during the COVID-19 pandemic. Key Messages: Better understanding of the pathophysiologic mechanisms underlying D-dimer formation would improve accuracy and specificity of D-dimer as biomarker for predicting long-term outcome of the severity of coronary artery disease and heart failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fibrin Fibrinogen Degradation ProductsHeart FailureCoronary Artery DiseaseHumansBiomarkersPrognosisCOVID-19SARS-CoV-2

Stichwörter der Autor:innen

Acute coronary syndromeCardiovascular prognosticationConfoundersD-dimerHeart failure

Substanzen

Fibrin Fibrinogen Degradation Productsfibrin fragment DBiomarkers

Autor:innen und Institutionen

  • Virginia Tech Carilion School of Medicine, Roanoke, Virginia, USA, kwu@carilionclinic.org.
  • University of Florida College of Medicine, Gainesville, Florida, USA.
  • Pauley Heart Center, Department of Internal Medicine, School of Medicine, Virginia Commonwealth University, Richmond, Virginia, USA, lei.xi@vcuhealth.org.

Zitieren

APA

Wu, K., Van Name, J., & Xi, L. (2025). D-Dimer as Biomarker for Prognosis of Coronary Artery Disease and Heart Failure: Reappraisal of Its Central Role. Cardiology, 151(2), 181-191. https://doi.org/10.1159/000546154

Vancouver

Wu K, Van Name J, Xi L. D-Dimer as Biomarker for Prognosis of Coronary Artery Disease and Heart Failure: Reappraisal of Its Central Role. Cardiology. 2025;151(2):181-191. doi:10.1159/000546154

BibTeX
@article{Wu2025,
  author = {Wu, Kainuo and Van Name, Jonathan and Xi, Lei},
  title = {D-Dimer as Biomarker for Prognosis of Coronary Artery Disease and Heart Failure: Reappraisal of Its Central Role},
  journal = {Cardiology},
  year = {2025},
  volume = {151},
  number = {2},
  pages = {181--191},
  doi = {10.1159/000546154}
}
Kostenlos starten →